In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Impact of Incubators on Venture Investing

This article was originally published in Start Up

Executive Summary

It seems logical that an incubator should facilitate venture fund investment in early-stage biomedical companies, since the incubator should accelerate technology commercialization. Unfortunately, few incubators--at least on the biotech side--have realized this potential, for a variety of reasons.

Related Content

Innovating on Biotech Investment Models: Likely--or Even Possible?
The Comparative Advantages of Medical Device Investing
The Comparative Advantages of Medical Device Investing





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts